Luminex's Q1 Revenues up 30 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today said its first-quarter revenues spiked 30 percent year over year, led by record consumables sales.

The Austin, Texas-based molecular diagnostics and multiplex test technologies firm said that revenues rose to $43.3 million for the three months ended March 31, compared to $33.3 million in the first quarter of 2010, exceeding Wall Street expectations of $39.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.